Miratas 25 Tablet ER

Discover how Miratas 25 Tablet ER, formulated by Intas Pharmaceuticals Ltd with Mirabegron (25mg), can assist with Treatment of Overactive bladder (OAB) symptoms. This page provides a comprehensive overview of this medication, including its primary applications and further detailed information to support your understanding. Feel free to add it to your favorites or compare it with other available options.

MRP: ₹
Packing:
Salt Combination: Mirabegron (25mg)
Brand: Intas Pharmaceuticals Ltd
Uses: Treatment of Overactive bladder (OAB) symptoms

Description

Miratas 25 Tablet ER is used to treat symptoms of overactive bladder that includes increased or frequent urination, urgent need to urinate and inability to control urination
It helps to relax the muscle surrounding the bladder and increase it's ability to store urine
Miratas 25 Tablet ER is advised to take it in a dose and duration as per prescription
It can be taken with or without food
Swallow the medicine as a whole without crushing or chewing it
You should not stop taking the medicine without consulting the doctor as it may lead to the worsening of your symptoms
The course of the treatment should be completed for better efficacy of the medicine.
Some common side effects of this medicine are constipation, headache, high blood pressure, nasal inflammation, urinary tract infection, rapid heartbeat, and joint pain
If any of the side effects bother you or persist, consult the doctor without delay.
Before receiving the treatment, inform your doctor if you are on any medication for any other health condition
If you are pregnant or breastfeeding, tell your doctor prior to the treatment
Patients with liver or kidney disease must be cautious while receiving the prescription and they must receive regular follow-ups as per the doctor’s advice.

Cautions

Liver:	CAUTION: Miratas 25 Tablet ER should be used with caution in patients with liver disease. Dose adjustment of Miratas 25 Tablet ER may be needed. Please consult your doctor. Use of Miratas 25 Tablet ER is not recommended in patients with severe liver disease.
Kidney:	CAUTION: Miratas 25 Tablet ER should be used with caution in patients with severe kidney disease. Dose adjustment of Miratas 25 Tablet ER may be needed. Please consult your doctor.
Driving:	SAFE: Miratas 25 Tablet ER does not usually affect your ability to drive.
Breast feeding:	CONSULT YOUR DOCTOR: Miratas 25 Tablet ER is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Pregnency:	CONSULT YOUR DOCTOR: Miratas 25 Tablet ER may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Alcohol:	CAUTION: Caution is advised when consuming alcohol with Miratas 25 Tablet ER. Please consult your doctor.
Drug Action:	Selective beta 3-adrenoceptor agonist (Bladder)
Therapeutic class:	UROLOGY
Habit Forming:	No
Chemical Class:	Anilide Derivative

Uses of Miratas 25 Tablet ER

In Treatment of Overactive bladder (OAB) symptoms Miratas 25 Tablet ER helps to treat uncontrollable contractions (spasms) of the bladder muscles that cause frequent urination, urgent need to urinate, and inability to control the passing of urine
It also relieves painful, or frequent urination and reduces the urgency to urinate that may occur with some infections of the urinary tract
This way it helps manage the overactive bladder symptoms efficiently.

Missed Doses

If you miss a dose of Miratas 25 Tablet ER, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.

FAQs